Part 6/9:
Amidst these fiscal discussions, President Trump lauded the work of Elon Musk, commending his initiatives and contributions in various sectors, which have sparked debates around government expenditure, particularly in research domains. The conversation flowed into budgetary considerations concerning the National Institute of Health, where Harris defended recent cuts, claiming they would ultimately serve to channel more funding directly into significant medical research, rather than supporting inflated overhead costs.
Harris asserted that modifying these funding approaches could foster innovation and enable a shift in focus toward preventative health measures, a crucial aspect considering the health crises highlighted by the COVID pandemic.